CIK 0001370053 · Non-accelerated filer<br>Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203828755
- Phone
- 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-03 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −8,292 | 16,585 | ||
| 2026-01-03 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise | +7,287 | 16,234 | ||
| 2026-01-03 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Unit | −7,287 | 14,575 | ||
| 2025-12-23 | Ware J. Anthony Director | Sale | −3,900 | $49.58 | $193K | 9,630 |
| 2025-12-23 | Schmid John P. Director | Other disposition | −11,068 | $51.00 | $564K | 0 |
| 2025-12-22 | Lizzul Paul F. Chief Medical Officer | Option exercise 10b5-1 | +1,500 | $18.50 | $28K | 28,467 |
| 2025-12-22 | Lizzul Paul F. Chief Medical Officer | Sale 10b5-1 | −1,500 | $50.00 | $75K | 26,967 |
| 2025-12-22 | Lizzul Paul F. Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,500 | 83,500 | ||
| 2025-12-22 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +10,000 | $20.16 | $202K | 19,401 |
| 2025-12-22 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −10,000 | $50.00 | $500K | 9,401 |
| 2025-12-22 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −10,000 | 60,600 | ||
| 2025-12-22 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise 10b5-1 | +10,000 | $14.02 | $140K | 18,947 |
| 2025-12-22 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale 10b5-1 | −10,000 | $51.00 | $510K | 8,947 |
| 2025-12-22 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −10,000 | 43,000 | ||
| 2025-12-18 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale 10b5-1 | −141 | $46.99 | $7K | 8,947 |
| 2025-12-17 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise 10b5-1 | +10,000 | $14.02 | $140K | 19,088 |
| 2025-12-17 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale 10b5-1 | −10,000 | $46.00 | $460K | 9,088 |
| 2025-12-17 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −10,000 | 53,000 | ||
| 2025-12-16 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +10,000 | $20.16 | $202K | 25,126 |
| 2025-12-16 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −9,365 | $44.62 | $418K | 15,761 |
Page 9 of 17 · 339 trades